4//SEC Filing
Anand Bhaskar 4
Accession 0001599298-24-000135
CIK 0001599298other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 5:26 PM ET
Size
5.1 KB
Accession
0001599298-24-000135
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Common Stock
2024-09-11$22.70/sh+22,026$499,990→ 131,426 total
Footnotes (1)
- [F1]Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of September 11, 2024, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person at a purchase price of $22.70 per share. The transaction closed on September 13, 2024.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001890784
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 5:26 PM ET
- Size
- 5.1 KB